Transmission of human immunodeficiency virus and hepatitis C virus through liver transplantation

Liver Transplantation

Volumn 14, Issue 11, 2008, Pages 1603-1608

  Ahn, Joseph ^a,b   Cohen, Stanley M ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; EFAVIRENZ PLUS EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; TACROLIMUS; VALGANCICLOVIR;

ACUTE GRAFT REJECTION; ACUTE KIDNEY FAILURE; AGED; ARTICLE; ASCITES; BLOOD SAMPLING; CASE REPORT; CD4 LYMPHOCYTE COUNT; CHEMOPROPHYLAXIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC ERROR; DONOR SELECTION; DRUG DOSE REDUCTION; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENERAL CONDITION DETERIORATION; HEPATIC ENCEPHALOPATHY; HEPATITIS C; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MEDICAL RECORD REVIEW; NUCLEIC ACID ANALYSIS; ORGAN DONOR; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SEPSIS; VIREMIA; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGED; FEMALE; HEPACIVIRUS; HEPATITIS C; HIV; HIV INFECTIONS; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RISK; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS;

EID: 57849157866     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21534     Document Type: Article

References (30)

1. Quarto M, Germinario C, Fontana A, Barbuti S. HIV transmission through kidney transplantation from a living donor. N Engl J Med 1989;320:1754.
2. Samuel D, Castaing D, Adam R, Saliba F, Chamaret S, Misset JL, et al. Fatal acute HIV infection with aplastic anaemia, transmitted by liver graft. Lancet 1988;1:1221-1222.
3. Simonds RJ, Holmberg SD, Hurwitz RL, Coleman TR, Botten ?eld S, Conley LJ, et al. Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. N Engl J Med 1992;326:726-732.
4. Centers for Disease Control. Human immunodeficiency virus infection transmitted from an organ donor screened for HIV antibody - North Carolina. MMWR Morb Mortal Wkly Rep 1987;36:306-308.
5. Prompt CA, Reiss MM, Grillo FM, Kopstein J, Kraemer E, Manfro R, et al. Transmission of AIDS virus at renal transplantation. Lancet 1985;2:672.
6. Schwarz A, Hoffmann F, L'Age-Stehr J, Tegzess AM, Offermann G. Human immunodeficiency virus transmission by organ donation. Transplantation 1987;44:21-24.
7. L'Age-Stehr J, Schwarz A, Offermann G, Langmaack H, Bennhold I, Niedrig M, Koch MA. HTLV-III infection in kidney transplant recipients. Lancet 1985;2:1361-1362.
8. Kumar P, Pearson JE, Martin DH, Leech SH, Buisseret PD, Bezbak HC, et al. Transmission of human immunodeficiency virus by transplantation of a renal allograft, with development of the acquired immunodeficiency syndrome. Ann Intern Med 1987;106:244-245.
9. Centers for Disease Control. Testing donors of organs, tissues, and semen for antibody to human T-lymphotrophic virus type III/ lymphoadenopathy-associated virus. MMWR Morb Mortal Wkly Rep 1985;34:294.
10. The Organ Procurement and Transplantation Network. Available at: http://www.optn.org/latestdata/rptdata.asp. Accessed March 2008.
11. Busch MP, Lee LL, Satten GA, Henrard DR, Farzadegan H, Nelson KE, et al. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors. Transfusion 1995;35:91-97.
12. Horsburgh CR Jr, Ou C-Y, Jason J, Holmberg SD, Longini IM Jr, Schable C, et al. Duration of human immunodeficiency virus infection before detection of antibody. Lancet 1989;16:637-640.
13. Busch MP, Glynn SA, Stramer SL, Strong DM, Caglioti S, Wright DJ, et al. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 2005; 45:254-264.
14. Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, Peddada L, et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 2003;17:1871-1879.
15. Centers for Disease Control. Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissue and organs. MMWR Recomm Rep 1994;43:1-17.
16. Pereira BJG, Milford EL, Kirkman RL, Levey AS. Transmission of hepatitis C virus by organ transplantation. N Engl J Med 1991;325:454-460.
17. Tugwell BD, Patel PR, Williams IT, Hedberg K, Chai F, Nainan OV, et al. Transmission of hepatitis C virus to several organ and tissue recipients from an antibody-negative donor. Ann Intern Med 2005;143:648-654.
18. Centers for Disease Control. Hepatitis C virus transmission from an antibody-negative organ and tissue donor - United States, 2000-2002. MMWR Morb Mortal Wkly Rep 2003;52:273-276.
19. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. N Engl J Med 1996;334:1685-1690.
20. Lackritz EM, Satten GA, Aberle-Grasse J, Dodd RY, Raimondi VP, Janssen RS, et al. Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. N Engl J Med 1995;333:1721-1725.
21. Dodd RY, Notari IV, Stramer SL. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion 2002;42:975-979.
22. Phelps R, Robbins K, Liberti T, Machuca A, Leparc G, Chamberland M, et al. Window-period human immunodeficiency virus transmission to two recipients by an adolescent blood donor. Transfusion 2004;44:929-933.
23. Schuttler CG, Caspari G, Jursch CA, Willems WR, Gerlich WH, Schaefer S. Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNA. Lancet 2000;355:41-42.
24. Jackson BR, Busch MP, Stramer SL, AuBuchon JP. The cost-effectiveness of NAT for HIV, HCV, and HBV in wholeblood donations. Transfusion 2003;43:721-729.
25. Marshall DA, Kleinman SH, Wong JB, AuBuchon JP, Grima DT, Kulin NA, Weinstein MC. Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C, and human immunodeficiency virus in the United States. Vox Sang 2004;86:28-40.
26. Duclos-Vallee JC, Feray C, Sebagh M, Teicher E, Roque-Alfonso AM, Roche B, et al. Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus. Hepatology 2008;47:407-417.
27. Mindikoglu AL, Regev A, Magder LS. Impact of human immunodeficiency virus on survival after liver transplantation: analysis of United Network for Organ Sharing Database. Transplantation 2008;85:359-368.
28. Schreibmann I, Gaynor JJ, Jayaweera D, Pyrsopoulos N, Weppler D, Tzakis A, et al. Outcomes after orthotopic liver transplantation in 15 HIV-infected patients. Transplantation 2007;84:697-705.
29. Samuel D, Weber R, Stock P, Duclos-Vallee JC, Terrault N. Are HIV-infected patients candidates for liver transplantation. J Hepatol 2008;48:697-707.
30. Roland ME, Barin B, Carlson L, Frassetto LA, Terrault NA, Hirose R, et al. HIV-infected liver and kidney transplant recipients:1-and3-yearoutcomes.AmJTransplant2008;8: 355-365.